C12N 9/6421
From mammals
Official title: {from mammals}
C12N9/6421 (From mammals) appears on 3,847 US grants and 4,486 published applications in this corpus.
Search patents in C12N- Granted patents
- 3,847
- Published applications
- 4,486
- Assignees
- 1,754
- Inventors
- 8,354
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 12 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 19 | 0 |
| 1982 | 15 | 0 |
| 1983 | 12 | 0 |
| 1984 | 16 | 0 |
| 1985 | 23 | 0 |
| 1986 | 13 | 0 |
| 1987 | 19 | 0 |
| 1988 | 24 | 0 |
| 1989 | 20 | 0 |
| 1990 | 48 | 0 |
| 1991 | 49 | 0 |
| 1992 | 68 | 0 |
| 1993 | 69 | 0 |
| 1994 | 57 | 0 |
| 1995 | 53 | 0 |
| 1996 | 69 | 0 |
| 1997 | 102 | 0 |
| 1998 | 159 | 0 |
| 1999 | 158 | 0 |
| 2000 | 145 | 0 |
| 2001 | 146 | 24 |
| 2002 | 123 | 257 |
| 2003 | 131 | 436 |
| 2004 | 104 | 269 |
| 2005 | 86 | 185 |
| 2006 | 133 | 203 |
| 2007 | 160 | 138 |
| 2008 | 103 | 135 |
| 2009 | 78 | 181 |
| 2010 | 100 | 134 |
| 2011 | 82 | 122 |
| 2012 | 73 | 119 |
| 2013 | 69 | 130 |
| 2014 | 86 | 156 |
| 2015 | 92 | 155 |
| 2016 | 90 | 177 |
| 2017 | 104 | 161 |
| 2018 | 110 | 162 |
| 2019 | 126 | 195 |
| 2020 | 111 | 185 |
| 2021 | 139 | 209 |
| 2022 | 97 | 163 |
| 2023 | 94 | 161 |
| 2024 | 91 | 175 |
| 2025 | 89 | 148 |
| 2026 | 51 | 106 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement6 Oct 2026US 12,753,411 B2The Brigham and Women S Hospital, Inc.
- Method for analyzing protein29 Sep 2026US 12,747,465 B2Hitachi, Ltd.
- Mutant protease and use thereof15 Sep 2026US 12,735,692 B2Kao Corporation
- Complement factor I and complement factor I cofactor, vectors encoding therefor and therapeutic use8 Sep 2026US 12,728,171 B2Novartis Pharmaceuticals UK Limited
- Adamts13 protein variants and uses thereof8 Oct 2026US 2026/0308560 A1Sanquin IP B.V.
- Method for the Production of Pharmaceutically Active Recombinant Human Low Molecular Weight Urokinase8 Oct 2026US 2026/0308654 A1Cerbios-Pharma SA
- Antimicrobial defensin peptide folding variants1 Oct 2026US 2026/0297145 A1Donald Danforth Plant Science Center
- Antimicrobial nodule-specific cysteine-rich peptide folding variants1 Oct 2026US 2026/0297146 A1Donald Danforth Plant Science Center
- Non-human animal, kit, and method for producing replacement organ24 Sep 2026US 2026/0283124 A1The Jikei University
Most cited
By later US patents
- Plasminogen activator derivatives616US 4,640,835 ANippon Chemiphar Co., Ltd. · 1987
- Isolation of exogenous recombinant proteins from the milk of transgenic mammals500US 4,873,316 ABiogen, Inc. · 1989
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Modified peptides as therapeutic agents359US 6,660,843 B1Amgen Inc. · 2003
- Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor346US 7,906,111 B2The Trustees of the University of Pennsylvania · 2011